Clinical impact of portal vein pulsatility on the prognosis of hospitalized patients with acute heart failure

Table 3 Changes in the biochemical and echocardiographic data of patients with heart failure

Parameter	Admission	Discharge	P value
Laboratory data
Albumin (mg/dL)	3.5 ± 0.4	3.4 ± 0.5	0.14
AST (IU/L)	61.4 ± 17.8	23.8 ± 15.0	0.06
ALT (IU/L)	46 ± 12.4	19 ± 2.0	0.06
Total bilirubin (mg/dL)	1.0 ± 0.6	0.8 ± 0.4	< 0.01
BUN (mg/dL)	28.3 ± 12.1	28.4 ± 12.4	0.50
Creatinine (mg/dL)	1.5 ± 1.4	1.4 ± 0.9	0.30
eGFR (mL/min/1.73 m2)	43.7 ± 18.1	43.7 ± 18.5	0.99
Hb (g/dL)	11.8 ± 2.5	11.6 ± 2.4	0.30
BNP (pg/mL)	1010 ± 1181	396 ± 626	< 0.01
TTE
EF (%)	42 ± 16	44 ± 14	0.51
TRPG (mmHg)	31.3 ± 12.1	25.2 ± 8.9	< 0.01
TAPSE (mmHg)	16.5 ± 4.9	17.4 ± 3.7	0.43
IVC (mm)	16.5 ± 4.2	14.2 ± 2.9	< 0.01

Data are mean ± SD. AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; BNP: Brain natriuretic peptide; BUN: Blood urea nitrogen; EF: Ejection fraction; eGFR: Estimated glomerular filtration rate; Hb: Hemoglobin; IVC: Inferior vena cava; TAPSE: Tricuspid annular plane systolic excursion; TRPG: Tricuspid regurgitation pressure gradient; TTE: Transthoracic echocardiography.